<DOC>
	<DOCNO>NCT01280188</DOCNO>
	<brief_summary>This open-label dose-titration study Japanese Central Diabetes Insipidus ( CDI ) patient design demonstrate efficacy safety orally-disintegrating tablet desmopressin .</brief_summary>
	<brief_title>A Study Minirin Melt Japanese Patients With Central Diabetes Insipidus ( CDI ) .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Insipidus</mesh_term>
	<mesh_term>Diabetes Insipidus , Neurogenic</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Participants must document Central Diabetes Insipidus ( CDI ) least two follow four criterion ( ad ) : 1 . Failure increase urine osmolality 300 mOsm/kg period fluid deprivation sufficient raise plasma osmolality sodium upper limit normal level reference laboratory ( usually 295 mOsm/kg 148 mEq/l , respectively ) 2 . Complete continuous control DI desmopressin therapy without `` breakthrough '' diuresis , hypernatremia , hyponatremia , symptom sign water intoxication . 3 . A deficient plasma vasopressin response osmotic nonosmotic stimulation . 4 . Absence posterior pituitary bright spot T1 weight midsagittal magnetic resonance imaging ( MRI ) brain . Given write informed consent prior trialrelated procedure perform 24 hour urine volume ( mL ) , urine osmolality ( mOsm/kg ) , urine specific gravity , serum sodium ( mEq/L ) maintain normal level desmopressin nasal administration Outpatient The participant , investigator 's opinion , otherwise healthy Be willing able comply protocol requirement include restriction water intake Presence history nephrogenic diabetes insipidus diabetes mellitus Presence uncorrected hypothyroidism , hypoadrenalism hypogonadism Abnormalities disease oral cavity might affect release absorption drug Unable place waterintake restriction start two hour bedtime Presence hypothalamus abnormality lead thirst disorder Evidence hepatic , renal , cardiac , pulmonary dysfunction Uncontrolled hypertension Treatment another investigational product within past 3 month Concurrent treatment diuretic , chlorpropamide , tricyclic antidepressant , indomethacin , carbamazepine Alcohol dependency drug abuse Breastfeeding , pregnant , likely become pregnant A mental condition , lack decisionmaking ability , dementia speech handicap Any reason Investigator believe inappropriate</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Diabetes</keyword>
</DOC>